Business profile not generated.
Run python -m application.cli.business_profile run --market US --one HAO, then regenerate the site.
Issue 000 | U.S. Pilot | US
HAO
Haoxi Health Technology Ltd
Needs Review
Stale Filing
20-F | 2025-10-20
Filing currency: USD
Margin of Safety
83.6%
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 19,604,560USD
- Total Liabilities
- 4,218,884USD
- NCAV
- 15,385,676USD
- Cash
- n/a
- NCAV per share
- 9.09USD/share
- Evidence
- 2 annual | 3 quarterly
Business Profile
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Known Unknowns
Only 3 quarterly periods available from Data Vault for this company.
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Medium | Filing
Some rows are based on older filing data and require manual freshness review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-06-30
20-F
USD
|
2024-06-30
20-F
USD
|
|---|---|---|
| Revenue | 537,646 | 48,519,836 |
| Operating Income | -1,999,903 | 1,717,248 |
| Net Income | 3,876,680 | 1,291,667 |
| Cash From Operations | -3,358,082 | -747,576 |
| Capex | n/a | -55,367 |
| Free Cash Flow | n/a | -802,943 |
| Cash And Equivalents | n/a | 6,655,734 |
| Accounts Receivable | 460,272 | 226,747 |
| Inventory | n/a | n/a |
| Total Current Assets | 19,604,560 | 15,379,830 |
| Total Assets | 21,595,314 | 15,506,573 |
| Total Current Liabilities | 3,885,065 | 3,866,575 |
| Total Liabilities | 4,218,884 | 4,234,618 |
| Shareholders Equity | 17,376,430 | 11,271,955 |
| Shares Outstanding | n/a | n/a |
| Shares Outstanding Diluted | n/a | n/a |
| Weighted Avg Shares Diluted | 2,397,036 | 30,600,000 |
| Weighted Avg Shares Basic | 2,334,136 | 30,600,000 |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
Only 3 quarterly periods available from Data Vault for this company.
| Metric |
2024-12-31
6-K
USD
|
2024-06-30
6-K
USD
|
2023-12-31
6-K
USD
|
|---|---|---|---|
| Revenue | 23,954,998 | 1,185,130 | 23,503,910 |
| Operating Income | -127,351 | 1,717,248 | 818,372 |
| Net Income | -232,533 | 531,469 | 760,198 |
| Cash From Operations | -2,250,334 | -747,576 | 301,000 |
| Capex | -5,135 | -55,367 | -16,162 |
| Free Cash Flow | -2,255,469 | -802,943 | 284,838 |
| Cash And Equivalents | n/a | 6,655,734 | n/a |
| Total Current Assets | 19,820,350 | 15,379,830 | n/a |
| Total Liabilities | 3,324,049 | 4,234,618 | n/a |
| Shares Outstanding | n/a | n/a | n/a |
| Shares Outstanding Diluted | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 1,814,800 | 30,600,000 | 1,179,200 |
| Weighted Avg Shares Basic | 1,814,800 | 30,600,000 | 1,179,200 |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 19,820,350USD | us-gaap:AssetsCurrent | 2024-12-31 | 1.00 |
sec/companyfacts/cik=0001954594/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001954594\companyfacts.json |
| Total Liabilities | 3,324,049USD | us-gaap:Liabilities | 2024-12-31 | 1.00 |
sec/companyfacts/cik=0001954594/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001954594\companyfacts.json |
| Cash | n/a | derived | 2024-12-31 | n/a | n/a |
| Shares Outstanding | 1,814,800 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | 2024-12-31 | 1.00 |
sec/companyfacts/cik=0001954594/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001954594\companyfacts.json |
| NCAV | 16,496,301USD | derived | 2024-12-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 9.09USD | derived | 2024-12-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 83.6% | derived | 2024-12-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / weighted_avg_shares_diluted
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- CIK
- 0001954594
- Company ID
- n/a
- Selected Annual Source
- n/a
- Selected Quarterly Source
- n/a
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 3
- Imported At
- 2026-07-04T23:04:30+00:00
- Rendered At
- 2026-07-05T09:06:29+00:00
Run Audit
- Mary Run
- 1ec055d81d1a42a39490a83bb9e1f22f
- Mary As Of
- 2026-07-03
- Accession
- 0001213900-25-100369
- CIK
- 0001954594
- Mary Filing Date
- 2025-10-20
- Filing Currency
- USD
- Internal Discount
- 83.6%
- Source State
- Stale Filing
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2025-10-20; mary_accession=0001213900-25-100369; mary_cik=0001954594; gnni_supporting_filing_date=2025-10-20; internal_discount=0.836414; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review